Deerland Probiotics & Enzymes

  • Member Carlsquare GmbH
  • Sector Life Sciences
  • Date completed 11.11.2019
  • Client Bifodan
  • Country Denmark
  • Acquirer Deerland Probiotics & Enzymes
  • Country United States

Carlsquare advised the shareholders of Bifodan in relation to a sale and partial reinvestment into Deerland Probiotics & Enzymes, a platform investment of US-based Roundtable Healthcare Partners.

Carlsquare GmbH
sold to

Get Started

Find out how the Globalscope family can help you realise your business dreams.